<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Naproxen - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Naproxen</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Analgesia / Anti-inflammatory</div>
      <h1>Naproxen</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Naproxen 250mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Acute musculoskeletal pain / inflammatory pain</strong></p>
        <ul>
          <li>250–500 mg PO twice daily as needed (use 1–2 x 250 mg tablets per dose)</li>
          <li>Use the lowest effective dose for the shortest duration</li>
        </ul>
        <p><strong>Dysmenorrhea (if relevant onboard)</strong></p>
        <ul>
          <li>500 mg PO once, then 250 mg PO every 6–8 hours as needed (max daily limits per local guidance)</li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Mild–moderate pain (especially inflammatory/musculoskeletal)</li>
          <li>Dysmenorrhea</li>
          <li>Acute gout or other inflammatory flares (protocol/diagnosis dependent)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <p><strong>Avoid/contraindicated:</strong></p>
        <ul>
          <li>NSAID hypersensitivity (incl. ASA/NSAID-exacerbated respiratory disease)</li>
          <li>Active GI bleeding or active peptic ulcer disease</li>
          <li>Severe renal impairment or significant acute kidney injury</li>
          <li>Peri-operative CABG setting</li>
          <li>Pregnancy: avoid especially in 3rd trimester (ductal/renal fetal risks)</li>
        </ul>
        <p><strong>Use caution in:</strong></p>
        <ul>
          <li>Older adults, dehydration, CKD risk, heart failure, uncontrolled HTN</li>
          <li>Concurrent anticoagulants/antiplatelets, systemic steroids, heavy alcohol use (bleeding risk)</li>
          <li>History of GI ulcer/bleed (risk–benefit; consider local gastroprotection practice)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Dyspepsia, nausea</li>
          <li>GI ulceration/bleeding (can occur without warning)</li>
          <li>Fluid retention, ↑BP; can worsen heart failure</li>
          <li>Renal function deterioration (higher risk with dehydration/CKD)</li>
          <li>Hypersensitivity/bronchospasm in susceptible patients</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Take with food if GI upset occurs</li>
          <li>Avoid combining with other NSAIDs (ibuprofen/ketorolac/etc.)</li>
          <li>If patient is on low-dose ASA for cardiac indications: NSAIDs may increase bleeding risk; document and use caution</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Pain relief and function</li>
          <li>GI symptoms (melena/hematemesis, persistent epigastric pain)</li>
          <li>BP/edema</li>
          <li>Renal function if prolonged use or higher-risk patient (where feasible)</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Higher risk in dehydration, limited labs, and limited evac options: be conservative with duration/dose</li>
          <li>Document start date/time and reassess frequently; stop if GI bleed symptoms or significant BP/edema occur</li>
          <li>Avoid stacking NSAIDs when multiple prescribers are involved (clear med reconciliation onboard)</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li><a href="https://pdf.hres.ca/dpd_pm/00065437.PDF" target="_blank" rel="noopener">Health Canada – Naproxen Product Monograph (PDF)</a></li>
          <li><a href="https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fniah-spnia/alt_formats/pdf/services/nurs-infirm/clini/adult/musculo-eng.pdf" target="_blank" rel="noopener">Health Canada – FNIHB Adult Musculoskeletal Clinical Guidelines (PDF)</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
